Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINTRAVENOUSStandard

PEMETREXED DISODIUM

PEMETREXED DISODIUM

Standard Dose
EQ 500MG BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PEMETREXED DISODIUM is listed in Drugs@FDA under application 215479 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient PEMETREXED DISODIUM Form and strength POWDER;INTRAVENOUS - EQ 500MG BASE/VIAL Sponsor MEITHEAL Submission history Latest submission status date: 2022-12-13 00:00:00.

Structured Monograph

Clinical summary

Approval overview PEMETREXED DISODIUM is listed in Drugs@FDA under application 215479 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient PEMETREXED DISODIUM Form and strength POWDER;INTRAVENOUS - EQ 500MG BASE/VIAL Sponsor MEITHEAL Submission history Latest submission status date: 2022-12-13 00:00:00. Submission type: ORIG.

Monitoring

  • Marketing status: Prescription
  • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.